Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorALDEBERT, G.
dc.contributor.authorFAILLIE, J. L.
dc.contributor.authorHILLAIRE-BUYS, D.
dc.contributor.authorMURA, T.
dc.contributor.authorCARRIERE, I.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELCOURT, Cecile
ORCID: 0000-0002-2099-0481
IDREF: 035105291
dc.contributor.authorCREUZOT-GARCHER, C.
dc.contributor.authorVILLAIN, M.
dc.contributor.authorDAIEN, V.
dc.date.accessioned2020-10-19T07:24:54Z
dc.date.available2020-10-19T07:24:54Z
dc.date.issued2018-07-01
dc.identifier.issn2168-6165en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/11391
dc.description.abstractEnImportance: Amyloid-beta is a major component of retinal drusen, the primary lesions of age-related macular degeneration (AMD), and autopsy and animal models suggested that anticholinergic drug (ACD) use increased brain amyloid-beta deposition. Objective: To investigate the association between exposure to ACDs and late AMD (features of neovascular AMD or geographic atrophy of the retinal pigment epithelium in at least 1 eye). Design, Setting and Participants: A multicenter case-control study in 4 French ophthalmologic centers comprising 200 cases with late AMD and 200 controls enrolled from July 2016 to June 2017. Exposures: Exposure to at least 3 months of ACDs started before AMD diagnosis was recorded during a specific interview. A dose-effect association with cumulative exposure duration and Anticholinergic Burden Score was explored. The association between ACD exposure and AMD was assessed by multivariate logistic regression analysis adjusted for age, sex, smoking status, family history of AMD, alcohol consumption, and use of anticoagulant and anti-inflammatory drugs. Odds ratios (ORs) and 95% confidence intervals were estimated. Main Outcomes and Measures: Association between exposure to ACDs and late AMD. Results: Among case participants, the mean (SD) age was 74.8 (9.2) years, 129 (64.5%) were women, 192 (96%) were white, 65 (32.5%) had geographic atrophy, 135 (67.5%) had neovascular AMD, 116 (58%) had unilateral AMD, and 84 (42%) had bilateral AMD. Among control participants, the mean (SD) age was 75.5 (7.2) years, with 116 (58%) women and 187 (93.5%) white participants. Twenty-six cases (13%) and 10 controls (5%) were exposed to ACDs throughout life for at least 3 months before AMD onset. Risk of AMD was increased with ever exposure to ACDs (adjusted OR [aOR], 2.84; 95% CI, 1.33-6.06; P = .007), high Anticholinergic Burden Score (>/=3) (aOR, 6.42; 95% CI, 1.38-29.92; P = .02), and longest cumulative exposure to ACD (>/=15 years) (aOR, 5.88; 95% CI, 1.22-28.31; P = .03). Conclusions and Relevance: Risk of late AMD may be increased with at least 3 months' use of ACDs. A dose-effect association was suggested by a greater association with prolonged use and high Anticholinergic Burden Score. Further studies, in particular those with longitudinal design, are needed to confirm this association.
dc.language.isoENen_US
dc.subject.enLEHA
dc.title.enAssociation of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration
dc.title.alternativeJAMA Ophthalmolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1001/jamaophthalmol.2018.1719en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29800005en_US
bordeaux.journalJAMA ophthalmologyen_US
bordeaux.page770-778en_US
bordeaux.volume136en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue7en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamLEHA_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=JAMA%20ophthalmology&rft.date=2018-07-01&rft.volume=136&rft.issue=7&rft.spage=770-778&rft.epage=770-778&rft.eissn=2168-6165&rft.issn=2168-6165&rft.au=ALDEBERT,%20G.&FAILLIE,%20J.%20L.&HILLAIRE-BUYS,%20D.&MURA,%20T.&CARRIERE,%20I.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée